Clinical trials
Phase 1 Neoplasms trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 3 |
| 2022 | 3 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 8 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 3 |
| pharmaand GmbH | 3 |
| AbbVie | 2 |
| Amgen | 2 |
| Checkpoint Therapeutics, Inc. | 2 |
| Celon Pharma SA | 1 |
| Debiopharm International SA | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Janssen Research & Development, LLC | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 24 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Colorectal Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Carcinoma, Renal Cell | 2 |
| Carcinoma, Transitional Cell | 2 |
| Lung Diseases | 2 |
| Lymphoma, Non-Hodgkin | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.